Loading
Latest filing published 17 Jan 2023 for Lexston Life Sciences Corp., €1,397.
Clinton Sharples appears in our data through filings on Lexston Life Sciences Corp. shares, published by SEDI. Over a trading history stretching from 12 September 2022 to 17 January 2023, the count stands at 6 filings.
Every open-market trade on record is a purchase: 4 purchases worth €19k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2023: 4 purchases and no sales on the market.
A typical purchase (the median) is worth €5,325. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 17 January 2023: an open-market purchase of €1,397, in Lexston Life Sciences Corp. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations